<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03401203</url>
  </required_header>
  <id_info>
    <org_study_id>AMCCV2017-11</org_study_id>
    <nct_id>NCT03401203</nct_id>
  </id_info>
  <brief_title>Debulking With Rotational Atherectomy Versus Balloon Angioplasty In Patients With In-stent Restenosis</brief_title>
  <acronym>ROTA-ISR</acronym>
  <official_title>A Prospective, Open Label, Multi-center, Dual Arm, Randomized Trial : The ROTA-ISR (Debulking With Rotational Atherectomy Versus Balloon Angioplasty In Patients With In-stent Restenosis) Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seung-Jung Park</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CardioVascular Research Foundation, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to establish the primary hypothesis that debulking with rotational atherectomy
      (RA) followed by balloon angioplasty (BA) is superior to BA alone for lesion preparation in
      patients with coronary in-stent restenosis (ISR) regarding the Optical coherence
      tomography(OCT)-measured in-segment minimal lumen area at 1 year.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 8, 2018</start_date>
  <completion_date type="Anticipated">June 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>OCT-measured in-segment minimal lumen area</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Device success rate</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angiographic outcomes immediate after procedure</measure>
    <time_frame>1 hour</time_frame>
    <description>In-segment and in-stent minimal lumen diameter and diameter stenosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OCT outcomes immediate after procedure : In-segment minimal lumen area loss</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OCT outcomes immediate after procedure : In-stent minimal lumen area loss</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OCT outcomes immediate after procedure : In-segment neointimal volume</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OCT outcomes immediate after procedure : In-stent neointimal volume</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angiographic outcomes : In-segment late lumen loss</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angiographic outcomes : In-stent late lumen loss</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angiographic outcomes : In-segment minimal lumen diameter</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angiographic outcomes : In-stent minimal lumen diameter</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angiographic outcomes : In-segment diameter stenosis</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angiographic outcomes : In-stent diameter stenosis</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OCT outcomes : in-segment late lumen area loss</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OCT outcomes : in-stent late lumen area loss</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>composite event rate</measure>
    <time_frame>1 year</time_frame>
    <description>A composite event of following factors is defined as the occurrence of any event from these events and denoted that event as the union of these.
Death (cardiac, vascular, non-cardiovascular)
Myocardial infarction (periprocedural, spontaneous)
Stent thrombosis (definite/probable)
Stroke
Any revascularization
Target lesion revascularization (TLR)
Target vessel revascularization (TVR)
Clinically significant bleeding (BARC type 2,3,4,5)
Target lesion failure (cardiac death, target vessel MI or ischemia-driven TLR)
Target vessel failure (cardiac death, target vessel MI or ischemia-driven TVR)
A composite of all-cause death, MI, any repeat revascularization
A composite of cardiac death, target vessel MI, stroke, or clinically significant bleeding (Bleeding Academic Research Consortium (BARC) type 2,3,4,5)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Coronary Vessels</condition>
  <arm_group>
    <arm_group_label>rotational atherectomy followed by balloon angioplasty</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>balloon angioplasty</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rotational atherectomy followed by balloon angioplasty</intervention_name>
    <description>Percutaneous coronary intervention</description>
    <arm_group_label>rotational atherectomy followed by balloon angioplasty</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Balloon angioplasty</intervention_name>
    <description>Percutaneous coronary intervention</description>
    <arm_group_label>balloon angioplasty</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men or women at least 19 years of age

          -  Subjects with coronary ISR planned revascularization

          -  The patient or guardian agrees to the study protocol and the schedule of clinical
             follow-up, and provides informed, written consent, as approved by the appropriate
             Institutional Review Board/Ethical Committee of the respective clinical site.

        Exclusion Criteria:

          -  Complex lesion anatomy that disables rotational atherectomy

          -  Any clinically significant abnormality identified at the screening visit, physical
             examination, laboratory tests, or electrocardiogram which, in the judgment of the
             Investigator, would preclude safe completion of the study.

          -  Life expectancy &lt; 1 years for any non-cardiac or cardiac causes

          -  Unwillingness or inability to comply with the procedures described in this protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Seung-jung Park, MD</last_name>
    <email>sjpark@amc.seoul.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jung-hee Ham, RN</last_name>
    <phone>82230104728</phone>
    <email>cvcrc5@amc.seoul.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seung-jung Park, MD</last_name>
      <email>sjpark@amc.seoul.kr</email>
    </contact>
    <investigator>
      <last_name>Seung-jung Park, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 25, 2017</study_first_submitted>
  <study_first_submitted_qc>January 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 17, 2018</study_first_posted>
  <last_update_submitted>May 9, 2018</last_update_submitted>
  <last_update_submitted_qc>May 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Seung-Jung Park</investigator_full_name>
    <investigator_title>Professor, Division of Cardiology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, South Korea</investigator_title>
  </responsible_party>
  <keyword>ISR</keyword>
  <keyword>ROTA</keyword>
  <keyword>DEB</keyword>
  <keyword>PCI</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

